Key result
Cichorium intybus administration before ischemia improved infarct size, arrhythmias, and cardiac markers in a rat model of ischemic reperfusion, likely via chemokine receptor type 4 up-regulation.
Why the study?
Cichorium intybus is used in traditional medicine for heart disease, but its potential to up-regulate chemokine receptor type 4 and confer cardioprotective effects in ischemic reperfusion required evaluation.
Does Cichorium intybus extract improve ischemia-reperfusion injury in a rat model?
Does Cichorium intybus extract improve ischemia-reperfusion injury in a rat model?
Cichorium intybus extract demonstrates cardioprotective effects against ischemia-reperfusion injury in rats, potentially mediated by chemokine receptor type 4 up-regulation and antioxidant activity.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in rat ischemia-reperfusion; leaves open clinical translation of Cichorium intybus.
OBJECTIVES: Cichorium intybus is used in traditional medicine for various diseases including heart disease. This study aimed at evaluating the chemokine receptor type 4 up-regulation and cardioprotective effects of hydroalcoholic extract of C. intybus in a rat model of ischemic reperfusion. METHODS: Animals in four groups of eight rats each received vehicle or one of three doses of C. intybus (50, 100 or 200 mg/kg/d) for 14 days. Then they were subjected to 30 min of ischemia followed by 7 days of reperfusion. At the end of the experiment, blood specimens were prepared for serum assays. The level of myocardium chemokine receptor type 4 was also measured using RT-PCR. KEY FINDINGS: Cichorium intybus (CI-50) improved infarct size, episodes of the ventricular ectopic beat, ventricular tachycardia, and duration of ventricular tachycardia, QTc shortening. It also stabilized the ST segment changes and increased heart rate during ischemia. The blood pressure decreased in CI-50 group in comparison to the control and CI-200 group. C. intybus increased serum superoxide dismutase and reduced lactate dehydrogenase activity, Cardiac Troponin I and malondialdehyde levels. C. intybus led to an increase in the expression of chemokine receptor type 4. CONCLUSIONS: These findings suggest that C. intybus administration before ischemia is able to induce cardioprotective effect against ischemic reperfusion injury, probably through chemokine receptor type 4 over-expression and antioxidant activity.
No takes yet. Share an insight, caveat, or question.
Sedighi et al. (2021) studied Ischemic reperfusion injury (n=32). Hydroalcoholic extract of Cichorium intybus vs. Vehicle was evaluated on Infarct size, arrhythmias, cardiac markers, and chemokine receptor type 4 expression. Cichorium intybus administration before ischemia improved infarct size, arrhythmias, and cardiac markers in a rat model of ischemic reperfusion, likely via chemokine receptor type 4 up-regulation.
Synapse has enriched 10 related papers. Consider them for comparative context: